Stay updated on Semaglutide Once-Daily Tablets in Overweight Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page.

Latest updates to the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page
- Check7 days agoChange DetectedThe page shows a new revision tag, v3.5.4, indicating a small update to the Record History page; the previous revision tag, v3.5.3, is removed from the history.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA new revision entry v3.5.3 has been added to the study's record history, indicating the latest update. The previous revision v3.5.2 was removed from the visible history.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedRevision history updated to include v3.5.2 and remove v3.5.0.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3 in the Record History.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision history updated: added v3.4.3 and removed v3.4.2.SummaryDifference0.1%

- Check100 days agoChange DetectedLatest revision on 2026-02-05 (v3.4.2) adds Returned date, Quality Control Review Has Not Concluded, and new study sections such as Adverse Events, Outcome Measures (Results), Baseline Characteristics, and Participant Flow. It also removes the older government funding notice and the prior revision (v3.4.1).SummaryDifference2%

Stay in the know with updates to Semaglutide Once-Daily Tablets in Overweight Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page.